INSP
Inspire Medical Systems, Inc.
Key Financials
Operating Income
$51.0M
↑ 41.2%
Gross Profit
$778.8M
↑ 14.6%
Revenue
$912.0M
↑ 13.6%
EPS (Diluted)
$4.89
↑ 179.4%
Net Income
$145.4M
↑ 171.8%
Total Liabilities
$126.2M
↑ 6.3%
Shareholders' Equity
$781.2M
↑ 13.3%
Cash & Equivalents
$104.8M
↓ 30.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/13/2026 | View on SEC |
| SCHEDULE 13G | 8/12/2026 | View on SEC |
| 4 | 8/11/2026 | View on SEC |
| 144 | 8/7/2026 | View on SEC |
| 4 | 8/4/2026 | View on SEC |
| 10-Q | 8/3/2026 | View on SEC |
| 8-K | 8/3/2026 | View on SEC |
| SCHEDULE 13G/A | 7/31/2026 | View on SEC |
| SCHEDULE 13G/A | 7/28/2026 | View on SEC |
| 4 | 7/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | INSP |
| Company Name | Inspire Medical Systems, Inc. |
| CIK | 1609550 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 763-957-5037 |